Patents by Inventor Olivier Roche

Olivier Roche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180107840
    Abstract: The invention is a method for restoring to a factory state a secure element which is embedded in a first device and which comprises a set of data. The method comprises the steps of: classifying data of the set in three independent categories, retrieving from a second device a first entity configured to provide factory value of data of the first category, restoring all current data of the first category (C1) by factory value, retrieving from a third device a second entity configured to provide factory value of data of the second category, restoring factory value of data of the second category.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 19, 2018
    Applicant: GEMALTO SA
    Inventors: Nicolas BOULANGER, Thierry SILVESTRE, Olivier ROCHE, Pannawit THENGTRIRAT, Sylvain CHARBONNIER
  • Publication number: 20180107822
    Abstract: The invention is a method for managing a secure element that comprises an operating system and a software application including an executable part which is tied to the operating system through a plurality of links. The method comprises the following steps: on receipt of an un-map command, recording in a memory area of the secure element a description of said links using an intermediate language, replacing the operating system by a new operating system by keeping said memory area unchanged, on receipt of a re-map command by the secure element, restoring a new set of links between the executable part and the new operating system by using the description.
    Type: Application
    Filed: March 23, 2016
    Publication date: April 19, 2018
    Applicant: GEMALTO SA
    Inventors: Nicolas BOULANGER, Thierry SILVESTRE, Olivier ROCHE, Pannawit THENGTRIRAT, Sylvain CHARBONNIER
  • Patent number: 9724199
    Abstract: This orthopedic implant includes a polymer substrate with an outer surface intended to be secured to a bone tissue. The outer surface is covered with metal particles including titanium. The particles include large primary particles and small secondary particles. The primary particles and the secondary particles are evenly distributed over the outer surface.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: August 8, 2017
    Inventors: Michel Brax, Jean-Louis Charissoux, Sébastien Lustig, Pascal Maman, Olivier Roche, Guillaume Venet
  • Patent number: 9414532
    Abstract: The invention provides an electrical power module, including power transistors, and control components for controlling said power transistors, said module being cooled, in particular, by heat conduction. The module of the invention further includes a main substrate of the AMB/Si3N4 type carrying the power transistors, this main substrate itself constituting a heat-dissipating baseplate for dissipating the heat generated by the power transistors by being arranged in the module to be directly in contact with the carrier structure that provides cooling by conduction when said module is in place, and a ceramic substrate carrying the control components, this ceramic substrate itself being carried by the main substrate.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: August 9, 2016
    Assignee: SAGEM DEFENSE SECURITE
    Inventor: Olivier Roche
  • Publication number: 20150077942
    Abstract: The invention provides an electrical power module, including power transistors, and control components for controlling said power transistors, said module being cooled, in particular, by heat conduction. The module of the invention further includes a main substrate of the AMB/Si3N4 type carrying the power transistors, this main substrate itself constituting a heat-dissipating baseplate for dissipating the heat generated by the power transistors by being arranged in the module to be directly in contact with the carrier structure that provides cooling by conduction when said module is in place, and a ceramic substrate carrying the control components, this ceramic substrate itself being carried by the main substrate.
    Type: Application
    Filed: May 13, 2013
    Publication date: March 19, 2015
    Inventor: Olivier Roche
  • Publication number: 20150045904
    Abstract: This orthopaedic implant includes a polymer substrate with an outer surface intended to be secured to a bone tissue. The outer surface is covered with metal particles including titanium. The particles include large primary particles and small secondary particles. The primary particles and the secondary particles are evenly distributed over the outer surface.
    Type: Application
    Filed: February 19, 2013
    Publication date: February 12, 2015
    Inventors: Michel BRAX, Jean-Louis CHARISSOUX, Sébastien LUSTIG, Pascal MAMAN, Olivier ROCHE, Guillaume Venet
  • Publication number: 20140350051
    Abstract: The present invention relates to compounds of the formula (I) wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.
    Type: Application
    Filed: July 24, 2014
    Publication date: November 27, 2014
    Inventors: Luca Gobbi, Georg Jaeschke, Olivier Roche, Rosa Maria Rodriguez Sarmiento, Lucinda Steward
  • Patent number: 8829029
    Abstract: The present invention relates to compounds of the formula (I) wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: September 9, 2014
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Luca Gobbi, Georg Jaeschke, Olivier Roche, Rosa Maria Rodriguez Sarmiento, Lucinda Steward
  • Patent number: 8748430
    Abstract: The present invention is concerned with novel sulfonamides of formula I wherein R1, R2, Ar, Hetaryl, m and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: June 10, 2014
    Assignee: Hoffmann-La Roche Inc
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Patent number: 8691846
    Abstract: The present invention relates to piperidine sulphonamide derivatives of formula wherein Ar1, Ar2, R1, R2, m and n are as defined in the description and claims, or pharmaceutically suitable acid addition salts thereof. The compounds of formula I are orexin receptor antagonists and the related compounds can be useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder or sleep disorders associated with neurological diseases.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: April 8, 2014
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Publication number: 20130217729
    Abstract: The present invention relates to piperidine sulphonamide derivatives of formula wherein Ar1, Ar2, R1, R2, m and n are as defined in the description and claims, or pharmaceutically suitable acid addition salts thereof. The compounds of formula I are orexin receptor antagonists and the related compounds can be useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder or sleep disorders associated with neurological diseases.
    Type: Application
    Filed: April 2, 2013
    Publication date: August 22, 2013
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Patent number: 8415350
    Abstract: The present invention relates to compounds of the general formula as dual modulators of the 5-HT2a and D3 receptors useful against CNS disorders, wherein A, R1, R2, n, p, q and r are as defined in the specification.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: April 9, 2013
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Luca Gobbi, Georg Jaeschke, Thomas Luebbers, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Lucinda Steward
  • Patent number: 8350028
    Abstract: The present invention is concerned with 2-aminoquinoline derivatives of formula I wherein R1 and R2 are as described herein and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them, and methods for their manufacture. These compounds are 5-HT5A receptor antagonists, useful for the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: January 8, 2013
    Assignee: Hofmann-La Roche Inc.
    Inventors: Sabine Kolczewski, Claus Riemer, Olivier Roche, Lucinda Steward, Juergen Wichmann, Thomas Woltering
  • Publication number: 20120238602
    Abstract: The present invention relates to piperidine sulphonamide derivatives of formula wherein Ar1, Ar2, R1, R2, m and n are as defined in the description and claims, or pharmaceutically suitable acid addition salts thereof. The compounds of formula I are orexin receptor antagonists and the related compounds can be useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder or sleep disorders associated with neurological diseases.
    Type: Application
    Filed: May 23, 2012
    Publication date: September 20, 2012
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Publication number: 20120232084
    Abstract: The present invention is concerned with novel sulfonamides of formula I wherein R1, R2, Ar, Hetaryl, m and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.
    Type: Application
    Filed: May 23, 2012
    Publication date: September 13, 2012
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Publication number: 20120196058
    Abstract: The invention relates to a process for adsorptive coloration of anodically oxidized surfaces of aluminum and/or aluminum alloys, characterized in that a) an aqueous dyebath is provided, said aqueous dyebath containing an organic dye that fluoresces on irradiation with UV light of a wavelength between 300 and 400 nm, containing not more than 0.4 g/liter of alkaline earth metal ions and having a pH between 4.0 and 10, b) said anodically formed surface is colored by immersion in and/or spraying with said dyebath (a) at a temperature between 10 and 50° C., and c) the colored surface is sealed.
    Type: Application
    Filed: September 9, 2010
    Publication date: August 2, 2012
    Applicant: CLARIANT FINANCE (BVI) LIMITED
    Inventors: Marcus Kleinert, Harald Oswald, Elena Weinbender, Olivier Roche
  • Patent number: 8227613
    Abstract: The invention is concerned with novel heteroaryl carboxamide derivatives of formula (I), wherein m, X, Y, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: July 24, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jean-Michel Adam, Johannes Aebi, Alfred Binggeli, Luke Green, Guido Hartmann, Hans P. Maerki, Patrizio Mattei, Fabienne Ricklin, Olivier Roche
  • Patent number: 8207220
    Abstract: The present invention is concerned with novel sulfonamides of formula I wherein R1, R2, Ar, Hetaryl, m and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: June 26, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Patent number: 8202888
    Abstract: The present invention relates to piperidine sulphonamide derivatives of formula wherein Ar1, Ar2, R1, R2, m and n are as defined in the description and claims, or pharmaceutically suitable acid addition salts thereof. The compounds of formula I are orexin receptor antagonists and the related compounds can be useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder or sleep disorders associated with neurological diseases.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: June 19, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers-Evans
  • Patent number: 8188284
    Abstract: The present invention relates to compounds of formula (I) wherein A, R1, R2, R3, R4, and R5 are as described herein, pharmaceutical compositions containing them, and methods for their manufacture. These compounds are 5-HT5A receptor antagonists and are useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: May 29, 2012
    Assignee: Hoffman-La Roche Inc.
    Inventors: Sabine Kolczewski, Claus Riemer, Olivier Roche, Lucinda Steward, Juergen Wichmann, Thomas Woltering